DANIELLA ARELLANO: Open Payments
NPI 1689064602 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,272 in 174 payments from 22 companies in 2025. Trend: 2023 $3,711 · 2024 $3,270 · 2025 $3,272
Food & beverage: $3,266Education: $7
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 16 | $407 |
| Janssen Biotech, Inc. | 13 | $344 |
| Incyte Corporation | 14 | $273 |
| Galderma Laboratories, L.P. | 24 | $234 |
| GENZYME CORPORATION | 10 | $214 |
| Regeneron Healthcare Solutions, Inc. | 16 | $211 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $193 |
| PFIZER INC. | 9 | $162 |
| ABBVIE INC. | 10 | $153 |
| Lilly USA, LLC | 6 | $150 |
Products named: Bimzelx, DUPIXENT, TREMFYA, OPZELURA, NEMLUVIO, Winlevi, CIBINQO, TALTZ.
Industry payments across TX — which companies pay providers there.
